30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Mullennix Stephen

Track

Insider profile

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return 15% 8.2% 15.1%
Success rate 94% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Mullennix Stephen's trades of Urogen Pharma Ltd's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-04-28 2020-04-27
S Sale
10,091 -19.0%
132.60
US$1,272,344 		10,091 -19.0% 132.60 US$1,272,344
2020-02-18 2020-02-14
S Sale
24,758 +14.5%
266.51
US$202,804 		24,758 +14.5% 266.51 US$202,804
2020-01-28 2020-01-27
S Sale
57,424 -41.6%
396.17
US$1,962,690 		57,424 -41.6% 396.17 US$1,962,690
2019-05-16 2019-05-14
S Sale
608 -10.2%
37.98
US$23,092 		608 -10.2% 37.98 US$23,092
2019-03-07 2019-02-14
S Sale
2,804 -39.9%
37.30
US$104,589 		2,804 -39.9% 37.30 US$104,589